OTCMKTS:KDSKF DSM-Firmenich (KDSKF) Stock Price, News & Analysis $25.30 0.00 (0.00%) As of 10/17/2024 Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsHeadlinesSEC Filings About DSM-Firmenich Stock (OTCMKTS:KDSKF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DSM-Firmenich alerts:Sign Up Key Stats Today's Range$25.30▼$25.3050-Day Range$25.30▼$25.3052-Week Range$12.50▼$120.00VolumeN/AAverage Volume303 shsMarket CapitalizationN/AP/E Ratio26.69Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewDSM the Life Sciences and Materials Sciences Company Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSMs products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam.Read More… Receive KDSKF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DSM-Firmenich and its competitors with MarketBeat's FREE daily newsletter. Email Address KDSKF Stock News HeadlinesKepler Capital Sticks to Their Buy Rating for DSM-Firmenich AG (DSFIR)February 20 at 8:30 AM | markets.businessinsider.comDSM-firmenich Launches 1 Billion-Euro Share Buyback After Earnings RiseFebruary 14, 2025 | wsj.comNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry.February 22, 2025 | Brownstone Research (Ad)DSM-Firmenich to launch up to 1 billion euro buyback after slight profit beatFebruary 14, 2025 | msn.comBarclays Keeps Their Buy Rating on DSM-Firmenich AG (DSFIR)February 14, 2025 | markets.businessinsider.comUBS Keeps Their Buy Rating on DSM-Firmenich AG (DSFIR)February 14, 2025 | markets.businessinsider.comDSM-Firmenich stock rises on Q4 earnings beatFebruary 13, 2025 | msn.comDSM-Firmenich to launch up to 1 billion euro buyback after strong resultsFebruary 13, 2025 | msn.comSee More Headlines KDSKF Stock Analysis - Frequently Asked Questions How have KDSKF shares performed this year? DSM-Firmenich's stock was trading at $25.30 at the beginning of 2025. Since then, KDSKF stock has increased by 0.0% and is now trading at $25.30. View the best growth stocks for 2025 here. How do I buy shares of DSM-Firmenich? Shares of KDSKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorBasic Materials Industry Specialty Chemicals Sub-IndustryN/A Current SymbolOTCMKTS:KDSKF CUSIPN/A CIK1339422 Webwww.dsm.com Phone(145) 578-8111FaxN/AEmployees19,263Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio26.69 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:KDSKF) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DSM-Firmenich AG Please log in to your account or sign up in order to add this asset to your watchlist. Share DSM-Firmenich With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.